Idexx Laboratories (IDXX) EBITDA Margin Growth (1y) (2010 - 2026)
Analysis
Idexx Laboratories (IDXX) EBITDA Margin Growth (1y) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.57 Bn | 40.38 Bn | 779.09 Mn | 136.00 |
| 2 | Zoetis | 30.57 Bn | 28.90 Bn | 1.05 Bn | -368.00 |
| 3 | Elanco Animal Health | 11.47 Bn | 10.94 Bn | 798.00 Mn | 40.00 |
| 4 | Phibro Animal Health | 1.43 Bn | 1.35 Bn | 134.40 Mn | 323.00 |
| 5 | Immucell | 87.38 Mn | 78.52 Mn | 2.44 Mn | 1,809.00 |
| 6 | Zhengye Biotechnology Holding | 64.40 Mn | 57.30 Mn | - | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 136.00 |
| Mar 31, 2026 | 8.00 |
| Dec 31, 2025 | 152.00 |
| Sep 30, 2025 | 95.00 |
| Jun 30, 2025 | 734.00 |
| Mar 31, 2025 | 69.00 |
| Dec 31, 2024 | 21.00 |
| Sep 30, 2024 | 108.00 |
| Jun 30, 2024 | -510.00 |
| Mar 31, 2024 | -14.00 |
| Dec 31, 2023 | -13.00 |
| Sep 30, 2023 | 98.00 |
| Jun 30, 2023 | 1,058.00 |
| Mar 31, 2023 | 146.00 |
| Dec 31, 2022 | 247.00 |
| Sep 30, 2022 | 121.00 |
| Jun 30, 2022 | -1,057.00 |
| Mar 31, 2022 | -215.00 |
| Dec 31, 2021 | -81.00 |
| Sep 30, 2021 | 407.00 |